Shares of Aurobindo Pharma Ltd fell 2.5 percent to ... The quarter also benefited from a one-time Rs 100 crore impact across various cost lines. Citi found the management commentary underwhelming ...

Stocks to Watch: Aurobindo Pharmas consolidated net profit fell 0.6% to Rs 903.47 crore despite of 11.9% increase in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24. Akums Drugs & ...

Aurobindo Pharma experienced a slight dip in Q4FY25 net profit, despite a revenue increase. However, the company saw significant growth in net profit and revenue for the entire fiscal year 2024-25 ...

Aurobindo Pharma posted a marginal decrease in its net profit at ₹903 crore in the fourth quarter ended March 31, 2025, compared with ₹907 crore in the corresponding quarter of the previous ...

As many as 220 companies are going to share their financial reports for the fourth quarter and the fiscal ending March 2025 on Monday, May 26. This period refers to the company’s performance during ...

General Insurance Corp, Aurobindo Pharma, Blue Dart Express, and Vadilal Industries will be among 221 companies to release their earnings report for the fourth quarter (Q4) of the financial year ...

The domestic equity benchmark indices, Sensex and Nifty 50, are expected to open higher on May 26, following positive cues from global markets. Asian markets traded higher, while the US stock ...

Two new 100% mortgage deals, designed for buyers who are struggling to save for a deposit and can’t rely on financial help from the ‘Bank of Mum and Dad’, have launched this month. April Mortgages is ...